Skip to main content
Top
Published in: Pathology & Oncology Research 2/2019

01-04-2019 | Nutrition | Original Article

Relationship Between -2028 C/T SELP Gene Polymorphism, Concentration of Plasma P-Selectin and Risk of Malnutrition in Head and Neck Cancer Patients

Authors: Tomasz Powrózek, Radosław Mlak, Anna Brzozowska, Marcin Mazurek, Paweł Gołębiowski, Teresa Małecka-Massalska

Published in: Pathology & Oncology Research | Issue 2/2019

Login to get access

Abstract

Until today there is a lack of molecular factors, that could predict either cancer malnutrition or cachexia. Among potential mechanisms, that contribute to development of above syndromes, the systemic inflammatory response with overproduction of cytokines and adhesion molecules is the most likely. Recent papers suggested crucial role of P-selectin adhesion molecule in the initiation of leukocytes recruitment to the site of injury during inflammation, promotion of tumor aggressiveness and contribution to cancer cachexia. The aim of the study was to investigate SELP -2028 C/T polymorphism as a risk factor of malnutrition in 66 head and neck cancer (HNC) patients subjected to radiotherapy. Genotyping was conducted by real-time PCR method by means of TaqMan SNP Genotyping Assay. P-selectin Human ELISA Kit was used to determine P-selectin concentration in each extracted plasma samples. CC homozygous subjects had 4-fold higher risk score of being qualified as severely malnourished compared to other genotype carriers (p = 0.015). However, the TT homozygous patients were at lowest risk of severe weight loss >10% during the therapy period (OR = 0.20; p = 0.019). We also noted, that CC genotype carriers had significantly higher risk of early death incidence compared to CT or TT genotype (median survival time: 29 vs 34 months; HR = 3.02; p = 0.0085). Studied SELP -2028 C/T seems to be a novel attractive predictive factor of cancer malnutrition in HNC patients, perhaps in a future, patients carrying unfavorable CC genotype could be earlier scheduled for pharmaceutical intervention with parenterall nutrition, therefore they could be prevented from the development of severe malnutrition or even cachexia.
Appendix
Available only for authorised users
Literature
1.
go back to reference O’Neill J, Shaha A (2011) Nutrition management of patients with malignancies of the head and neck. Surg Clin North Am 91:631–639CrossRefPubMed O’Neill J, Shaha A (2011) Nutrition management of patients with malignancies of the head and neck. Surg Clin North Am 91:631–639CrossRefPubMed
2.
go back to reference Alshadwi A, Nadershah M, Carlson ER, Young LS, Burke PA, Daley BJ (2013) Nutritional considerations for head and neck cancer patients: a review of the literature. J Oral Maxillofac Surg 71(11):1853–1860CrossRefPubMed Alshadwi A, Nadershah M, Carlson ER, Young LS, Burke PA, Daley BJ (2013) Nutritional considerations for head and neck cancer patients: a review of the literature. J Oral Maxillofac Surg 71(11):1853–1860CrossRefPubMed
3.
go back to reference Unsal D, Mentes B, Akmansu M, Uner A, Oguz M, Pak Y (2006) Evaluation of nutritional status in cancer patients receiving radiotherapy: a prospective study. Am J Clin Oncol 29:183–188CrossRefPubMed Unsal D, Mentes B, Akmansu M, Uner A, Oguz M, Pak Y (2006) Evaluation of nutritional status in cancer patients receiving radiotherapy: a prospective study. Am J Clin Oncol 29:183–188CrossRefPubMed
4.
go back to reference Gorenc M, Kozjek NR, Strojana P (2015) Malnutrition and cachexia in patients with head and neck cancer treated with (chemo)radiotherapy. Rep Pract Oncol Radiother 20(4):249–258CrossRefPubMedPubMedCentral Gorenc M, Kozjek NR, Strojana P (2015) Malnutrition and cachexia in patients with head and neck cancer treated with (chemo)radiotherapy. Rep Pract Oncol Radiother 20(4):249–258CrossRefPubMedPubMedCentral
6.
7.
go back to reference Donohoe CL, Ryan AM, Reynolds JV (2011, 601434) Cancer Cachexia: mechanisms and clinical implications. Gastroenterol Res Pract 2011:1–13CrossRef Donohoe CL, Ryan AM, Reynolds JV (2011, 601434) Cancer Cachexia: mechanisms and clinical implications. Gastroenterol Res Pract 2011:1–13CrossRef
9.
go back to reference Geng JG, Chen M, Chou KC (2004) P-selectin cell adhesion molecule in inflammation, thrombosis, cancer growth and metastasis. Curr Med Chem 11(16):2153–2160CrossRefPubMed Geng JG, Chen M, Chou KC (2004) P-selectin cell adhesion molecule in inflammation, thrombosis, cancer growth and metastasis. Curr Med Chem 11(16):2153–2160CrossRefPubMed
10.
go back to reference Reiner AP, Carlson CS, Thyagarajan B, Rieder MJ, Polak JF, Siscovick DS, Nickerson DA, Jacobs DR Jr, Gross MD (2008) Soluble P-selectin, SELP polymorphisms, and atherosclerotic risk in European-American and African-African young adults: the coronary artery risk development in young adults (CARDIA) study. Send to Arterioscler Thromb Vasc Biol 28(8):1549–1555CrossRef Reiner AP, Carlson CS, Thyagarajan B, Rieder MJ, Polak JF, Siscovick DS, Nickerson DA, Jacobs DR Jr, Gross MD (2008) Soluble P-selectin, SELP polymorphisms, and atherosclerotic risk in European-American and African-African young adults: the coronary artery risk development in young adults (CARDIA) study. Send to Arterioscler Thromb Vasc Biol 28(8):1549–1555CrossRef
11.
go back to reference Burkhardt J, Blume M, Petit-Teixeira E, Hugo Teixeira V, Steiner A, Quente E, Wolfram G, Scholz M, Pierlot C, Migliorini P, Bombardieri S, Balsa A, Westhovens R, Barrera P, Radstake TRDJ, Alves H, Bardin T, Prum B, Emmrich F, Cornelis F, Ahnert P, Kirsten H (2014) Cellular adhesion gene SELP is associated with rheumatoid arthritis and displays differential allelic expression. PLoS One 9(8):e103872CrossRefPubMedPubMedCentral Burkhardt J, Blume M, Petit-Teixeira E, Hugo Teixeira V, Steiner A, Quente E, Wolfram G, Scholz M, Pierlot C, Migliorini P, Bombardieri S, Balsa A, Westhovens R, Barrera P, Radstake TRDJ, Alves H, Bardin T, Prum B, Emmrich F, Cornelis F, Ahnert P, Kirsten H (2014) Cellular adhesion gene SELP is associated with rheumatoid arthritis and displays differential allelic expression. PLoS One 9(8):e103872CrossRefPubMedPubMedCentral
12.
go back to reference Fearon KC, Glass DJ, Guttridge DC (2012) Cancer Cachexia: mediators, signaling, and metabolic pathways. Cell Metab 16(2):153–166CrossRefPubMed Fearon KC, Glass DJ, Guttridge DC (2012) Cancer Cachexia: mediators, signaling, and metabolic pathways. Cell Metab 16(2):153–166CrossRefPubMed
13.
go back to reference Avan A, Avan A, Le Large TY et al (2014) AKT1 and SELP polymorphisms predict the risk of developing Cachexia in pancreatic Cancer patients. PLoS ONE 9(9):e108057CrossRefPubMedPubMedCentral Avan A, Avan A, Le Large TY et al (2014) AKT1 and SELP polymorphisms predict the risk of developing Cachexia in pancreatic Cancer patients. PLoS ONE 9(9):e108057CrossRefPubMedPubMedCentral
14.
go back to reference Kaur R, Singh J, Kaur M (2017) Structural and functional impact of SNPs in P-selectin gene: a comprehensive in silico analysis. Open Life Sciences 12(1):19–33CrossRef Kaur R, Singh J, Kaur M (2017) Structural and functional impact of SNPs in P-selectin gene: a comprehensive in silico analysis. Open Life Sciences 12(1):19–33CrossRef
15.
go back to reference Volcik KA, Ballantyne CM, Coresh J, Folsom AR, Boerwinkle E (2007) Specific P-selectin and P-selectin glycoprotein ligand–1 genotypes/haplotypes are associated with risk of incident CHD and ischemic stroke: the atherosclerosis risk in communities (ARIC) study. Atherosclerosis 195:e76–e82CrossRefPubMedPubMedCentral Volcik KA, Ballantyne CM, Coresh J, Folsom AR, Boerwinkle E (2007) Specific P-selectin and P-selectin glycoprotein ligand–1 genotypes/haplotypes are associated with risk of incident CHD and ischemic stroke: the atherosclerosis risk in communities (ARIC) study. Atherosclerosis 195:e76–e82CrossRefPubMedPubMedCentral
16.
go back to reference Jacobin VM, Deramchia K, Mornet S et al (2011) MRI of inducible P-selectin expression in human activated platelets involved in the early stages of atherosclerosis. NMR Biomed 24:413–424 Jacobin VM, Deramchia K, Mornet S et al (2011) MRI of inducible P-selectin expression in human activated platelets involved in the early stages of atherosclerosis. NMR Biomed 24:413–424
17.
go back to reference Miller MA, Kerry SM, Dong Y, Strazzullo P, Cappuccio FP (2004) Association between the Thr715Pro Pselectin gene polymorphism and soluble P-selectin levels in a multiethnic population in South London. Thromb Haemost 92:1060–1065CrossRefPubMed Miller MA, Kerry SM, Dong Y, Strazzullo P, Cappuccio FP (2004) Association between the Thr715Pro Pselectin gene polymorphism and soluble P-selectin levels in a multiethnic population in South London. Thromb Haemost 92:1060–1065CrossRefPubMed
18.
go back to reference Volcik KA, Ballantyne CM, Coresh J, Folsom AR, Wu KK, Boerwinkle E (2006) P-selectin Thr715Pro polymorphism predicts P-selectin levels but not risk of incident coronary heart disease or ischemic stroke in a cohort of 14595 participants: the atherosclerosis risk in communities study. Atherosclerosis 186:74–79CrossRefPubMed Volcik KA, Ballantyne CM, Coresh J, Folsom AR, Wu KK, Boerwinkle E (2006) P-selectin Thr715Pro polymorphism predicts P-selectin levels but not risk of incident coronary heart disease or ischemic stroke in a cohort of 14595 participants: the atherosclerosis risk in communities study. Atherosclerosis 186:74–79CrossRefPubMed
19.
go back to reference Kou L, Yang N, Chen G et al (2016) Association of SELP genetic polymorphisms and additional gene-smoking interaction on cardiovascular disease in Chinese Han population. Int J Clin Exp Pathol 9(9):9612–9618 Kou L, Yang N, Chen G et al (2016) Association of SELP genetic polymorphisms and additional gene-smoking interaction on cardiovascular disease in Chinese Han population. Int J Clin Exp Pathol 9(9):9612–9618
20.
go back to reference Morris DL, Graham RR, Erwig LP, Gaffney PM, Moser KL, Behrens TW, Vyse TJ, Graham DSC (2009) Variation in the upstream region of P-selectin (SELP) is a risk factor for SLE. Genes Immun 10:404–413CrossRefPubMedPubMedCentral Morris DL, Graham RR, Erwig LP, Gaffney PM, Moser KL, Behrens TW, Vyse TJ, Graham DSC (2009) Variation in the upstream region of P-selectin (SELP) is a risk factor for SLE. Genes Immun 10:404–413CrossRefPubMedPubMedCentral
21.
22.
go back to reference Johns N, Stretch C, Tan BHL (2017) New genetic signatures associated with cancer cachexia as defined by low skeletal muscle index and weight loss. J Cachexia Sarcopenia Muscle 8(1):122–130CrossRefPubMed Johns N, Stretch C, Tan BHL (2017) New genetic signatures associated with cancer cachexia as defined by low skeletal muscle index and weight loss. J Cachexia Sarcopenia Muscle 8(1):122–130CrossRefPubMed
Metadata
Title
Relationship Between -2028 C/T SELP Gene Polymorphism, Concentration of Plasma P-Selectin and Risk of Malnutrition in Head and Neck Cancer Patients
Authors
Tomasz Powrózek
Radosław Mlak
Anna Brzozowska
Marcin Mazurek
Paweł Gołębiowski
Teresa Małecka-Massalska
Publication date
01-04-2019
Publisher
Springer Netherlands
Published in
Pathology & Oncology Research / Issue 2/2019
Print ISSN: 1219-4956
Electronic ISSN: 1532-2807
DOI
https://doi.org/10.1007/s12253-018-00578-w

Other articles of this Issue 2/2019

Pathology & Oncology Research 2/2019 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine